Muriel Rogasik
Overview
Explore the profile of Muriel Rogasik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collet L, Telouk P, Albarede F, Girodet M, Maqua C, Rogasik M, et al.
Metabolomics
. 2024 Nov;
20(6):129.
PMID: 39520592
Objectives: While some metals have been reported as carcinogens or potential carcinogens, only few modern-standard datasets including a large number of elements are available. The present analysis established a first...
2.
Blay J, Casali P, Ray-Coquard I, Seckl M, Gietema J, de Herder W, et al.
Lancet Reg Health Eur
. 2024 Feb;
39:100861.
PMID: 38384730
About 500,000 patients with rare adult solid cancers (RASC) are diagnosed yearly in Europe. Delays and unequal quality of management impact negatively their survival. Since 2017, European reference networks (ERN)...
3.
Ballinger M, Pattnaik S, Mundra P, Zaheed M, Rath E, Priestley P, et al.
Science
. 2023 Jan;
379(6629):253-260.
PMID: 36656928
Cancer genetics has to date focused on epithelial malignancies, identifying multiple histotype-specific pathways underlying cancer susceptibility. Sarcomas are rare malignancies predominantly derived from embryonic mesoderm. To identify pathways specific to...
4.
Dony A, Belhabri A, Bertrand Y, Sebban C, Cony-Makhoul P, Sobh M, et al.
J Adolesc Young Adult Oncol
. 2019 Aug;
8(6):684-696.
PMID: 31411521
Management of adolescent and young adults (AYAs) cancer is very heterogeneous. In the case of lymphomas, outcomes are mostly favorable but there is still room for improvement. We retrospectively collected...
5.
Piperno-Neumann S, Piulats J, Goebeler M, Galloway I, Lugowska I, Becker J, et al.
Cancers (Basel)
. 2019 Jun;
11(6).
PMID: 31200439
Uveal melanoma (UM) is the most frequent primary ocular cancer in adults, accounting for 5% of all melanomas. Despite effective treatments for the primary tumour, up to 50% of UM...
6.
Swalduz A, Souquet P, Perol M, Moro-Sibilot D, Schiffler C, Chabaud S, et al.
Future Oncol
. 2019 Jun;
15(18):2139-2149.
PMID: 31185741
We performed a clinical audit of the management of patients with mutations, 1 year after the introduction of tyrosine kinase inhibitor (-TKI) in first-line treatment. Compliance was defined by tumor...
7.
Rasmussen V, Forrest L, Rogasik M, Girodet M, Meeus P, Sunyach M, et al.
Per Med
. 2018 May;
15(1):13-24.
PMID: 29714116
Aim: To compare Australian and French perceptions of genetics and preferences regarding the return of incidental findings. Methods: Participants from the International Sarcoma Kindred Study received a survey at intake...
8.
Penel-Page M, Ray-Coquard I, Larcade J, Girodet M, Bouclier L, Rogasik M, et al.
BMC Cancer
. 2015 Nov;
15:854.
PMID: 26541413
Background: The objective of this study is to explore the off-label use of targeted therapies (TTs) for patients with osteosarcoma registered within the French Sarcoma Group--Bone Tumor Study Group (GSF-GETO)...